26 October 2022 - On 1 September 2022, a Panel of the Patented Medicine Prices Review Board issued a decision that ...
21 October 2022 - Saskatchewan joined five provinces and one territory in implementing a biosimilar switching policy, allowing for reference ...
7 October 2022 - The PMPRB's guidelines explain how its staff monitor and review patented medicine prices to ensure they are ...
5 October 2022 - The CADTH recommendations are a step towards public funding of this treatment option for some patients with ...
21 September 2022 - The Schizophrenia Society of Canada is joined by the schizophrenia community across Canada in its disappointment with ...
6 September 2022 - Six health technology assessment bodies from three continents will join forces to collaborate on a range of ...
7 September 2022 - B.C. is last Canadian jurisdiction to fund Trikafta for patients with cystic fibrosis age 6 to 11. ...
7 September 2022 - A week after a B.C. family went public with its plea for a life-changing drug for ...
7 September 2022 - Further delays in access or complete denials of access to innovative drugs will hurt even more Canadians ...
1 September 2022 - CADTH is pleased to announce the launch of its new post-market drug evaluation program. ...
1 September 2022 - Provincial jurisdictions will make the final decision on public reimbursement. ...
29 August 2022 - Evelyn Larson visited a private clinic in Saskatoon only to find the Yukon did cover the treatment ...
18 August 2022 - High demand in the United States for a new weight-loss medication has indefinitely delayed its arrival ...
29 July 2022 - Amylyx Pharmaceuticals today announced that Albrioza (sodium phenylbutyrate and ursodoxicoltaurine) is now commercially available in Canada for ...
25 July 2022 - Reimbursement for Vascepa in Canada is now at more than 65% for publicly covered lives and private ...